People who are blind from birth never develop schizophrenia – what this tells us about the psychiatric condition

Understanding why people born blind never develop schizophrenia could transform how we think about and treat one of ...
BioSpace

Patient death prompts FDA pause on Newron’s Phase 3 schizophrenia study

The patient death occurred outside the U.S. and was deemed unrelated to Newron Pharmaceuticals’ investigational schizophrenia ...

Patient death puts Newron’s late-stage schizophrenia trial on ice

An independent international safety monitoring board has given the ENIGMA-TRS 1 trial the go-ahead to continue as planned.
BioSpace

BMS positions Cobenfy as safer alternative ahead of pivotal Alzheimer’s psychosis readout

After delaying a late-stage readout last year due to “irregularities” at certain study sites, pivotal data for Bristol Myers ...
MedPage Today on MSN

Novel Antipsychotic Shows Promise in Acute Schizophrenia

Downsides with current options leave a large unmet need for new therapies, researcher says ...
WBUR

You can recover from schizophrenia — I did. But the stigma of the disease prevents too many from getting treatment

"About 10% of people with schizophrenia will engage in violence during their lifetimes, which is three to four times higher than the general population, but people with schizophrenia are more likely ...

Serious mental illness is often connected to homelessness. It doesn’t have to be, Portland professor says

The lack of mental health care options for people with serious mental illnesses like bipolar disorder, post-traumatic stress ...
Psychiatry Advisor

Schizophrenia Shows Increased Risk for Cardiac Repolarization Heterogeneity

Schizophrenia was associated with cardiac electrical instability, suggesting arrhythmic vulnerability was an intrinsic ...
WDEF

Understanding Schizophrenia And Family Impact

A closer look at schizophrenia highlights early signs, ongoing stigma, and the role families play in daily care.
Healio

FDA approves Caplyta for relapse prevention in schizophrenia

The FDA has approved Johnson & Johnson’s supplemental new drug application for Caplyta among patients with schizophrenia at ...